Intra-atrial thrombosis and homozygous factor V Leiden mutation

被引:4
|
作者
Simioni, P
Scalia, D
Tormene, D
Bongiovi, S
Sardella, C
Girolami, A
机构
[1] UNIV PADUA,SCH MED,PADUA HOSP,I-35100 PADUA,ITALY
[2] UNIV PADUA,SCH MED,INST CARDIOVASC SURG,I-35100 PADUA,ITALY
[3] PIOVE SACCO HOSP,DEPT CARDIOL,PADUA,ITALY
关键词
thrombophilia; factor V Leiden; atrial thrombosis;
D O I
10.1177/107602969700300312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 55-year-old woman with a previous history of thrombotic manifestations developed large left atrial thrombosis. Coagulative screening demonstrated the presence of severe activated protein C resistance due to homozygous factor V Leiden mutation that could explain the thrombophilic state in this patient. No other associated coagulation defects predisposing to thrombosis were identified. At the time of diagnosis of intra-atrial thrombosis, the patient presented with a moderate mitral valve stenosis and atrial fibrillation of recent onset. Both these conditions may account for the presence of left atrial thrombosis but it is suggested that inherited thrombophilia due to homozygous factor V Leiden mutation might have represented an additional predisposing factor for the development of the thrombotic phenomenon. The role of coagulation defects predisposing to thrombosis in the pathogenesis of intracardial thrombosis in patients with or without valvular diseases is still unknown and proper studies are required.
引用
收藏
页码:215 / 217
页数:3
相关论文
共 50 条
  • [21] Homozygous Factor V Leiden presenting as irreversible chronic colon ischemia resulting from inferior mesenteric vein thrombosis
    Kevin Zheng
    Lawrence J. Brandt
    Darlene LeFrancois
    Clinical Journal of Gastroenterology, 2021, 14 : 1142 - 1146
  • [22] Homozygous Factor V Leiden presenting as irreversible chronic colon ischemia resulting from inferior mesenteric vein thrombosis
    Zheng, Kevin
    Brandt, Lawrence J.
    LeFrancois, Darlene
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (04) : 1142 - 1146
  • [23] Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency
    Zehnder, JL
    Jain, M
    BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (03) : 361 - 362
  • [24] Factor V Leiden Mutation in Severe Infection and Sepsis
    Levi, Marcel
    Schouten, Marcel
    Van't Veer, Cees
    van der Poll, Tom
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2011, 37 (08) : 954 - 959
  • [25] Factor V Leiden mutation in pregnancy
    Cohen, SM
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2004, 33 (03): : 348 - 353
  • [26] Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden
    Rintelen, C
    Mannhalter, C
    Ireland, H
    Lane, DA
    Knobl, P
    Lechner, K
    Pabinger, I
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (02) : 487 - 490
  • [27] Obstetric implications of the factor V Leiden mutation: A review
    Bloomenthal, D
    Delisle, MF
    Tessier, F
    Tsang, P
    AMERICAN JOURNAL OF PERINATOLOGY, 2002, 19 (01) : 37 - 47
  • [28] Should the factor V Leiden mutation be screened among ethnic Malays with venous thrombosis?
    Ng, H. J.
    Ghafar, A. Abdul
    Lim, L. C.
    Lee, L. H.
    Koay, E. S.
    THROMBOSIS RESEARCH, 2010, 125 (05) : 471 - 472
  • [29] Portal vein thrombosis in association with factor V Leiden mutation in a patient with hepatocellular carcinoma
    Gurgey, A
    Buyukpamukcu, M
    Baskut, C
    Yalcin, B
    Gogus, S
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 29 (03): : 224 - 225
  • [30] No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene
    Rintelen, C
    Mannhalter, C
    Lechner, K
    Eichinger, S
    Kyrle, PA
    Papagiannopoulos, M
    Schneider, B
    Pabinger, I
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (02) : 101 - 105